Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.
Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.
S. Kemp,J. Kuntze,4 Authors,B. Lippe
2005 · DOI: 10.1210/JC.2004-2513
Journal of Clinical Endocrinology and Metabolism · 126 Citations
TLDR
ISS patients in the GH registry demonstrate a significant increase in HtSDS with the safety profile similar to GH-deficient patients, and no new safety signals specific to the NCGS ISS population were observed.